Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a

被引:117
作者
Rosebeck, Shaun [1 ]
Leaman, Douglas W. [1 ]
机构
[1] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA
关键词
apoptosis; caspases; membrane potential; Bcl-2; Bax;
D O I
10.1007/s10495-008-0190-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
ISG12a is one of the most highly induced genes following treatment of cells with type I interferons (IFNs). The encoded protein belongs to a family of poorly characterized, low molecular weight IFN-inducible proteins that includes 6-16 (G1P3), 1-8U (IFITM3), and 1-8D (IFITM2). Our studies demonstrate that the ISG12a protein associates with or inserts into the mitochondrial membrane. Transient expression of ISG12a led to decreased viable cell numbers and enhanced sensitivity to DNA-damage induced apoptosis, effects that were blocked by Bcl-2 co-expression or treatment with a pan-caspase inhibitor. ISG12a enhanced etoposide induced cytochrome c release, Bax activation and loss of mitochondrial membrane potential. siRNA-mediated inhibition of ectopic ISG12a protein expression prevented the sensitization to etoposide-induced apoptosis and also decreased the ability of IFN-beta pretreatment to sensitize cells to etoposide, thereby demonstrating a role for ISG12a in this process. These data suggest that ISG12a contributes to IFN-dependent perturbation of normal mitochondrial function, thus adding ISG12a to a growing list of IFN-induced proteins that impact cellular apoptosis.
引用
收藏
页码:562 / 572
页数:11
相关论文
共 53 条
[1]
Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway [J].
Balachandran, S ;
Roberts, PC ;
Kipperman, T ;
Bhalla, KN ;
Compans, RW ;
Archer, DR ;
Barber, GN .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1513-1523
[2]
Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling [J].
Balachandran, S ;
Kim, CN ;
Yeh, WC ;
Mak, TW ;
Bhalla, K ;
Barber, GN .
EMBO JOURNAL, 1998, 17 (23) :6888-6902
[3]
Bani MR, 2004, MOL CANCER THER, V3, P111
[4]
Borden, 1998, Oncologist, V3, P198
[5]
BUDHU A, 2007, IN PRESS CARCINOGENE
[6]
Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821
[7]
IFN-β pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis [J].
Chawla-Sarkar, M ;
Leaman, DW ;
Jacobs, BS ;
Borden, EC .
JOURNAL OF IMMUNOLOGY, 2002, 169 (02) :847-855
[8]
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis [J].
Chawla-Sarkar, M ;
Lindner, DJ ;
Liu, YF ;
Williams, B ;
Sen, GC ;
Silverman, RH ;
Borden, EC .
APOPTOSIS, 2003, 8 (03) :237-249
[9]
CHEN Q, 1998, BLOOD, V123, P2183
[10]
G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells [J].
Cheriyath, Venugopalan ;
Glaser, Keith B. ;
Waring, Jeffrey F. ;
Baz, Rachid ;
Hussein, Mohamad A. ;
Borden, Ernest C. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (10) :3107-3117